CLINICAL_TRIALS
trial_result
· 2021-05-13
Clinical Trial Update: A Phase 1/2 Study to Evaluate MEDI4736 [Phase 1, Phase 2]
Summary
Phase 1/2 study update for MEDI4736 (durvalumab) in advanced solid tumors; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-13